262 related articles for article (PubMed ID: 35785473)
1. Alteration of microbiota antibody-mediated immune selection contributes to dysbiosis in inflammatory bowel diseases.
Michaud E; Waeckel L; Gayet R; Goguyer-Deschaumes R; Chanut B; Jospin F; Bathany K; Monnoye M; Genet C; Prier A; Tokarski C; Gérard P; Roblin X; Rochereau N; Paul S
EMBO Mol Med; 2022 Aug; 14(8):e15386. PubMed ID: 35785473
[TBL] [Abstract][Full Text] [Related]
2. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
3. Location-based prediction model for Crohn's disease regarding a novel serological marker, anti-chitinase 3-like 1 autoantibodies.
Sipeki N; Kovats PJ; Deutschmann C; Schierack P; Roggenbuck D; Papp M
World J Gastroenterol; 2023 Nov; 29(42):5728-5750. PubMed ID: 38075846
[TBL] [Abstract][Full Text] [Related]
4. J-chain expression is more prominent in immunoglobulin A2 than in immunoglobulin A1 colonic immunocytes and is decreased in both subclasses associated with inflammatory bowel disease.
Kett K; Brandtzaeg P; Fausa O
Gastroenterology; 1988 Jun; 94(6):1419-25. PubMed ID: 2452117
[TBL] [Abstract][Full Text] [Related]
5. Dynamic immunoglobulin responses to gut bacteria during inflammatory bowel disease.
Rengarajan S; Vivio EE; Parkes M; Peterson DA; Roberson EDO; Newberry RD; Ciorba MA; Hsieh CS
Gut Microbes; 2020 May; 11(3):405-420. PubMed ID: 31203722
[TBL] [Abstract][Full Text] [Related]
6. NOD2 deficiency increases retrograde transport of secretory IgA complexes in Crohn's disease.
Rochereau N; Roblin X; Michaud E; Gayet R; Chanut B; Jospin F; Corthésy B; Paul S
Nat Commun; 2021 Jan; 12(1):261. PubMed ID: 33431850
[TBL] [Abstract][Full Text] [Related]
7. Serum secretory IgA, IgA1 and IgA2 subclasses in inflammatory bowel and chronic liver diseases.
Soppi E; Granfors K; Leino R
J Clin Lab Immunol; 1987 May; 23(1):15-7. PubMed ID: 3612757
[TBL] [Abstract][Full Text] [Related]
8. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.
Nagao-Kitamoto H; Shreiner AB; Gillilland MG; Kitamoto S; Ishii C; Hirayama A; Kuffa P; El-Zaatari M; Grasberger H; Seekatz AM; Higgins PD; Young VB; Fukuda S; Kao JY; Kamada N
Cell Mol Gastroenterol Hepatol; 2016 Jul; 2(4):468-481. PubMed ID: 27795980
[TBL] [Abstract][Full Text] [Related]
9. Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy.
Merga Y; Campbell BJ; Rhodes JM
Dig Dis; 2014; 32(4):475-83. PubMed ID: 24969297
[TBL] [Abstract][Full Text] [Related]
10. Two-Sample Mendelian Randomization Analysis Investigates Causal Associations Between Gut Microbial Genera and Inflammatory Bowel Disease, and Specificity Causal Associations in Ulcerative Colitis or Crohn's Disease.
Liu B; Ye D; Yang H; Song J; Sun X; Mao Y; He Z
Front Immunol; 2022; 13():921546. PubMed ID: 35860271
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota changes in inflammatory bowel diseases and ankylosing spondilytis.
Cardoneanu A; Mihai C; Rezus E; Burlui A; Popa I; Cijevschi Prelipcean C
J Gastrointestin Liver Dis; 2021 Mar; 30(1):46-54. PubMed ID: 33548121
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin A Glycosylation Differs between Crohn's Disease and Ulcerative Colitis.
Clerc F; Reiding KR; de Haan N; Koeleman CAM; Hipgrave Ederveen AL; Manetti N; ; Dotz V; Annese V; Wuhrer M
J Proteome Res; 2023 Oct; 22(10):3213-3224. PubMed ID: 37641533
[TBL] [Abstract][Full Text] [Related]
13. The Underappreciated Role of Secretory IgA in IBD.
Bamias G; Kitsou K; Rivera-Nieves J
Inflamm Bowel Dis; 2023 Aug; 29(8):1327-1341. PubMed ID: 36943800
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease.
Palm NW; de Zoete MR; Cullen TW; Barry NA; Stefanowski J; Hao L; Degnan PH; Hu J; Peter I; Zhang W; Ruggiero E; Cho JH; Goodman AL; Flavell RA
Cell; 2014 Aug; 158(5):1000-1010. PubMed ID: 25171403
[TBL] [Abstract][Full Text] [Related]
15. Association between intestinal microbiota and inflammatory bowel disease.
Zhang Y; Si X; Yang L; Wang H; Sun Y; Liu N
Animal Model Exp Med; 2022 Dec; 5(4):311-322. PubMed ID: 35808814
[TBL] [Abstract][Full Text] [Related]
16. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
[TBL] [Abstract][Full Text] [Related]
17. Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid.
Kabeerdoss J; Jayakanthan P; Pugazhendhi S; Ramakrishna BS
Indian J Med Res; 2015 Jul; 142(1):23-32. PubMed ID: 26261163
[TBL] [Abstract][Full Text] [Related]
18. Periodontal and inflammatory bowel diseases: Is there evidence of complex pathogenic interactions?
Lira-Junior R; Figueredo CM
World J Gastroenterol; 2016 Sep; 22(35):7963-72. PubMed ID: 27672291
[TBL] [Abstract][Full Text] [Related]
19. Intestinal Microbiota and miRNA in IBD: A Narrative Review about Discoveries and Perspectives for the Future.
Oliveira ECS; Quaglio AEV; Magro DO; Di Stasi LC; Sassaki LY
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108339
[TBL] [Abstract][Full Text] [Related]
20. Mucosal immune systems of pediatric inflammatory bowel disease: A review.
Kudo T; Shimizu T
Pediatr Int; 2023; 65(1):e15511. PubMed ID: 36799518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
